Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs

Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs

FromProject Medtech


Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs

FromProject Medtech

ratings:
Length:
69 minutes
Released:
May 9, 2022
Format:
Podcast episode

Description


In this episode, Nick Accordino and Will Braeutigam from Deloitte and Duane Mancini discuss discuss SPACs, what are SPACs, why would a company want to go public, the differences in going public through an IPO vs. SPAC, strategic acquisition vs. going public, the myths of going public via a SPAC, preparing your company to go public, and so much more.
Nick Accordino LinkedIn
Will Braeutigam LinkedIn
Deloitte Website
Project Medtech Website
Duane Mancini LinkedIn
Project Medtech LinkedIn
Released:
May 9, 2022
Format:
Podcast episode

Titles in the series (100)

Join us as we sit down with leading experts in the Medtech Industry as they share success stories, advice, pitfalls, trends and innovations.